To answer the global threat of vector-borne diseases, the International Federation for Animal Health (IFAH) has commissioned a white paper to act as a framework for industry to take action and generate debate.
The white paper, independently authored by Oxford Analytica and produced with the support of The Bill and Melinda Gates Foundation, highlights the most urgent, new and emerging threats of vector-borne diseases to human and animal health, and ways forward for tackling the issue globally.
It has been discussed by leading industry influencers at a roundtable in Geneva with the specific objective of formulating strategies and partnerships across a variety of organisations from research bodies to policy makers. It is now available to download from the IFAH website.
Vector-borne diseases account for 17% of the global burden of all infectious diseases. The most deadly of which, malaria, causes an estimated 627,000 deaths annually.
Conditions that affect livestock can also have a significant economic impact, for example trypanosomiasis accounts for losses in cattle production of up to US$1.2b a year.
Combating vector-borne diseases is an ever-changing and complex challenge that is affected by many factors, including the impact of climate change on vector spread, habitat change introduced by humans and the increasing risk of insecticide resistance.
Carel du Marchie Sarvaas, executive director at IFAH said: “Vector-borne diseases are a topic of international significance that need to be debated head on.
“The white paper and roundtable will raise awareness of the importance and need to control these diseases and provide the evidence for solvers and donors who fund efforts to develop tools to control neglected vector-borne diseases.
“It includes a number of case studies from across the world and suggests proactive strategies for tackling them on a local, regional and global level.
“As the representative body for companies engaged in the research, development and manufacturing of animal medicines and health products, IFAH is uniquely positioned to address the challenges and help explore intrinsic links between human and animal health.”